Jun 17, 2020
Respira Technologies, Inc. announces plan to pursue FDA authorization for the RespiRxTM drug delivery platform as the first "vapor style" Nicotine Replacement Therapy targeting the 50% of smokers who want to quit
May 14, 2020
Achieve Reports Financial Results for First Quarter 2020 and Provides Update on Cytisinicline Development Program
Apr 08, 2020
FDA Approves First Generic of a Commonly Used Albuterol Inhaler to Treat and Prevent Bronchospasm
Mar 17, 2020
Major Pharmaceutical Company Selects Wellness BioSciences Rx As Exclusive Distributor for New CBD Product Category
Mar 13, 2020
Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program
Mar 12, 2020
Achieve Life Sciences Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting
Feb 04, 2020
Global Smoking Cessation and Nicotine De-Addiction Market to Expand at a CAGR of 4.5% Over 2018 to 2026, Reaching US$ 13.6 Bn by 2026: Transparency Market Research
Jan 02, 2020
FDA finalizes enforcement policy on unauthorized flavored cartridge-based e-cigarettes that appeal to children, including fruit and mint
Dec 09, 2019
Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program
Nov 06, 2019
Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program
Nov 05, 2019
Smokers Offered Fresh Hope With the UK Launch of VOKE
Sep 30, 2019
Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study
Sep 25, 2019
Remarks from Acting FDA Commissioner Ned Sharpless, M.D. as prepared for testimony before a U.S. House Energy and Commerce Subcommittee on FDA Regulation of Electronic Nicotine Delivery Systems and Investigation of Vaping Illnesses
Sep 13, 2019
Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
Sep 09, 2019
FDA warns JUUL Labs for marketing unauthorized modified risk tobacco products, including in outreach to youth
Sep 05, 2019
Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial
Sep 04, 2019
Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences
Aug 08, 2019
Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update
Jul 24, 2019
Philip Morris International Launches the World's Leading Heated-Tobacco Product in the UAE
Jul 23, 2019
Achieve Life Sciences Extends Collaboration with the National Institutes of Health to Advance the Development of Cytisinicline for Smoking Cessation